ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...
A session at ICON 2024. This is a sponsored guest post by Berkadia. Technical.ly is a free news resource thanks to financial supporters like Berkadia, a Technical.ly client. Each year, Berkadia’s ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positive recognition as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback